首页> 美国卫生研究院文献>BMC Womens Health >Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study
【2h】

Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study

机译:序贯E2水平而非卵巢最大直径估计值与西妥罗肽治疗卵巢过度刺激综合征高危女性的治疗效果相关:一项随机对照研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundOvarian hyperstimulation syndrome (OHSS) is an important condition with considerable morbidity and a small risk of mortality and most commonly results as an iatrogenic condition following follicular stimulation of the ovaries>. We aimed to evaluate safety and efficacy of 3-day cetrotide therapy started on day of oocyte retrieval (Day-0) in women at high-risk for development of ovarian hyperstimulation syndrome (OHSS) after GnRH agonist induction protocol.
机译:背景卵巢过度刺激综合征(OHSS)是一种重要的疾病,发病率较高,死亡风险较小,最常见的结果是卵泡刺激卵巢后发生医源性疾病。> 我们旨在评估3种药物的安全性和有效性在GnRH激动剂诱导方案后,发生卵巢过度刺激综合征(OHSS)的高危女性的卵母细胞取回日(第0天)开始进行Cetrotide天疗法。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号